SOURCE: IDenta Corp.

May 07, 2007 10:00 ET

International Drug & Explosives Detection Company IDenta Releases Summary of Progress in Florida

HEATHROW, FL -- (MARKET WIRE) -- May 7, 2007 -- IDenta Corp. (PINKSHEETS: IDTA) today released a summary of activities that occurred last week in Florida, the first stop on the company's current U.S. marketing mission. During the two and one-half day period, company officials attended five meetings, conducted an investor teleconference, and participated in a live internet broadcast.

From these meetings IDenta expects:

  1.  An order for drug detection kits for them to be assessed by a
      national law enforcement agency located in Central Florida.
  2.  The development of a formal business relationship with the
      National Association of Drug Free Workplaces, www.nadfw.com,
      headquartered in Altamonte Springs, Florida. NADFW develops programs
      for drug prevention and detection in businesses such as restaurant
      chains, the construction industry and manufacturing companies.
  3.  An agreement with Trinity Media Group to expand IDenta's investor
      relations program.
  4.  An increased role by SITCOM LLC, who coordinated and hosted IDenta's
      meetings at its Heathrow offices, to support the company's marketing
      and investor relations programs.
IDenta CEO Yaacov Shoham summed up the Florida agenda, "I was very impressed with every person and group we met with. The meetings afforded us the opportunity to establish important new business affiliations, as well as take crucial steps to expand our communications to shareholders, market makers and investment brokers."

During the meetings both Shoham and IDenta Chief Scientist Baruck Glastein spent considerable time detailing the significant advances that IDenta's two step drug detection process offers. The discussions centered on four points:

  1. How most drug detectors isolate only the chemical family -- not the
     specific substance.
  2. How IDenta's patented second step of its two step process does
     accurately identify the presence of the exact drug in question.
  3. How law enforcement agencies gain valuable time for prosecuting drug
     users and dealers by not sending hundreds of questionable samples to
     chemistry labs which often takes months to process.
  4. How laboratories can save thousands of dollars and hundreds of hours
     by recommending IDenta's products to greatly reduce the number of
     tested substances which turn out not to be the drug in question.
Concerning the company's investor conference and interview on www.mn1.com, Mr. Shoham expounded on the company's current U.S. and international sales activities citing pending orders from France, Indonesia and China. Additionally he stated that he expected that in the coming months IDenta would be filing all required forms that will keep the company in good standing with the new rankings that are being proposed on www.PinkSheets.com.

Shoham commented after the teleconference discussion, "I can appreciate the idea that some IDTA shareholders are anxious to see the company's products and IDTA stock jump to new plateaus, but unfortunately these matters take time. IDTA is a long-term investment that has the true potential for exponential increases at some point in the future, but we cannot hurry ahead without the right foundation to build both a strong international business, and a respectable, fact-supported stock value."

Members of the press, law enforcement agencies or investor relations wishing to conduct an interview, or wish to receive investor or product information should email identanews@sitcomllc.com with complete details for contact.

ABOUT IDENTA

Since 2003, IDenta Corporation has become recognized as a world-wide leader in the development of proprietary on-site drug detection kits and most recently explosive detection kits. IDenta develops, manufactures and distributes products for the both professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world. Information concerning IDenta's product line may be found at www.identa.biz.

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

Contact Information

  • Contact:

    For Investor Relations, lobbying interests or information
    concerning IDenta's products internationally contact:

    Yaacov Shoham
    IDenta Corp.
    CEO
    Tel: +972-52-6554487
    +972-8-9716874
    Fax: +972-8-9716875
    fpi@drugsdetector.com

    For Investor Relations in the United States contact:
    Randy Jacobs
    US Corporate Spokesman
    IDentaNews@sitcomllc.com
    1-800-316-9437